Top compounds associated with response to TPH2


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib CCLE pan-cancer AAC 0.023 0.6
mRNA BRD-K86535717 CTRPv2 pan-cancer AAC -0.036 0.6
mRNA ML210 CTRPv2 pan-cancer AAC 0.016 0.6
mRNA IPR-456 CTRPv2 pan-cancer AAC 0.019 0.6
mRNA salermide CTRPv2 pan-cancer AAC 0.023 0.6
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA itraconazole CTRPv2 pan-cancer AAC 0.019 0.6
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.6
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.018 0.6
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC 0.018 0.6
Download CSV